NCT04070742View on ClinicalTrials.gov

Dermal Phototoxicity Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 17, 2016

Primary Completion Date

September 7, 2016

Study Completion Date

October 1, 2016

Conditions
Healthy
Interventions
DRUG

FMX101

All Listed Sponsors
lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04070742 - Dermal Phototoxicity Study | Biotech Hunter | Biotech Hunter